Researchers develop “last defence” treatment against swine flu

July 01, 2010 04:16 pm | Updated November 28, 2021 09:04 pm IST - Hong Kong

Health workers watch a bank of monitors which display information on the temperatures of incoming passengers at the International Airport in Hong Kong. File photo

Health workers watch a bank of monitors which display information on the temperatures of incoming passengers at the International Airport in Hong Kong. File photo

Hong Kong researchers have developed a treatment for people infected by swine flu using the antibodies from blood plasma from patients who recovered from the disease, a media report said Thursday.

According to the study, 30 critically ill patients in Hong Kong were given the treatment after they failed to respond to antiviral drugs Tamilflu and Relenza and most recovered, the South China Morning Post reported, without giving detailed figures of the recoveries.

Antibodies in the plasma can kill the H1N1 virus in severely ill patients.

Dr. Ivan Hung, assistant professor of medicine at the University of Hong Kong, who led the study, said: “Some of them died subsequently, but we have enough evidence to conclude that the antibodies are an effective cure, as most patients have since recovered.” Dr. Hung thought the treatment could also be effective against other viruses.

The research team also included teams from the Hong Kong Red Cross and the Hospital Authority.

The H1N1 swine flu virus was discovered in Mexico in March last year. In Hong Kong, 282 people developed severe complications from the virus, and 80 of them died. More than 18,200 people died worldwide, according to the World Health Organization.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.